Marine-Origin Polysaccharides and Their Chemically Modified Derivatives as Sources of Advanced Biofunctional Materials for Biomedical Applications
Sousa V., Monteiro LPG., Rocha DHA., Rodrigues JMM., Borges J., Mano JF.
Narrative Review, published in Biomacromolecules (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Biomacromolecules (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40705978
- PMCID
- PMC12818769
- DOI
- 10.1021/acs.biomac.4c01682
- Citations
- 7
Abstract (original English)
Marine polysaccharides are widely available sustainable renewable macromolecules, which have attracted considerable attention owing to their enhanced biocompatibility, biodegradability, noncytotoxic, nonimmunogenic properties, and close similarity to the native cellular microenvironment of tissues and organs. Herein, a comprehensive overview of the main sources and properties of most studied cationic, anionic, and neutral marine-origin polysaccharides, their main chemical functionalization strategies, as well as their processing into advanced biofunctional materials/devices is provided. Several recent examples are given on the bottom-up processing of marine-origin polysaccharide-based biomaterials in the form of nano-/microparticles and capsules, nanofibers, thin films, membranes, hydrogels, cryogels, and (bio)inks to be used as high added-value antimicrobial coatings, adhesives, and wound dressings, or in food packaging, cosmetics, controlled drug delivery, in vitro disease modeling, or tissue engineering and regenerative medicine. The main challenges hampering the clinical translation and commercialization of most marine-origin polysaccharide-based biomaterials and devices, and future perspectives in the field are also discussed.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.